Point-of-care testing is one of those phrases that sounds simple until you're the person signing the purchase order. I'm the office administrator for a 40-person clinic. I manage all medical supply ordering—roughly $300,000 annually across 15 vendors. I report to both operations and finance. When our medical director asked me in 2023 to compare point-of-care testing (POC) against sending samples to a central lab, I expected a quick answer. I got a project that changed the way I evaluate every vendor.
Here's the framework I used, so you can see the comparison the way I wish I had: four dimensions—upfront cost, per-test cost, the costs that hide outside the quote, and how each option changes daily operations. If you're making this call for a hospital floor, a private clinic, or a veterinary practice, this is the comparison I wish someone had handed me.
What Is Point-of-Care Testing?
Point-of-care testing is basically a category, not a single machine. It covers glucose meters, electrolyte and blood gas analyzers, cardiac marker readers—anything that produces a clinical result while the patient is still within earshot. A central lab is where samples go when they need a bigger analyzer, a specialized technician, or a test that only gets run twice a week.
I actually had some context before starting. We run a Mindray DPM6 patient monitor in each exam room, and when we upgraded our medical imaging setup about two years ago, I spent half a day reading the Mindray M8 Elite manual cover to cover. So I knew what a well-supported device should look like. But a POC analyzer is a different purchase from a monitor or an ultrasound system, and I went into the comparison with an open mind.
What I didn't realize at first is that this isn't really a comparison between two machines. It's a comparison between two ways of paying for healthcare—and one of them hides its costs better than the other.
Round 1: Upfront Cost
The upfront gap is the first number you'll see on any price sheet. A point-of-care analyzer runs somewhere in the $3,000–$15,000 range depending on the test panel, automation level, and whether you choose the version with integrated quality control (do). The central lab costs nothing to establish: no capital purchase, no installation, no operator training. If you compare only upfront dollars, the lab wins, no contest.
But that's exactly the point. Upfront cost is the only number the vendor is guaranteed to tell you about. Here's something vendors don't advertise: the lab's "zero setup" arrangement usually comes with a monthly minimum contract. In my experience, even in months where our volume dropped, the base fee didn't move.
Verdict for round one: the central lab looks cheaper if you stop reading after the equipment line. I'm not saying the POC upfront cost disappears—it's a real capital request, and for a small clinic, that's a hard approval to get. But it's also the one number in this entire comparison that you'll truly know in advance.
Round 2: Per-Test Cost
This is where I almost made a classic rookie mistake.
The central lab's per-test price for our most-ordered panel—a basic metabolic panel plus CBC—was roughly 30% lower than the POC cartridge cost. On paper, clear win for the lab. But the lab's quote didn't include courier pickup. The POC cartridge price included everything: the reagent, the disposable, and the built-in quality control that runs every time you load a new cartridge.
Most buyers focus on the per-test number and completely miss the question behind it: what's actually included? The question everyone asks is "what's your price per test?" The question they should ask is "what's included in that number?" That one question has saved me more money than any negotiation tactic I've ever used.
There are also consumable dynamics on both sides that the per-test number can't capture. A POC cartridge that expires unused is money down the drain. A lab test you don't run is a test you don't pay for—except for the monthly minimum and the courier contract that doesn't care whether you sent one tube or forty.
Round 3: Hidden Costs—The One That Changed My Mind
This is the round that flipped my recommendation, and I want to be honest: I did not see it coming.
The central lab's hidden costs never showed up on any single invoice. They accumulated in the clinic's daily rhythm:
- Shipping. A daily courier pickup ran about $150 per month. Nobody had itemized it until I asked. That's $1,800 a year for a service I'd never once budgeted.
- Rejected samples. Underfilled tube, delayed pickup, wrong transport temperature—the lab rejects the sample and the patient comes back for a redraw. Each redraw costs staff time plus patient goodwill.
- Delayed decisions. A result that shows up in 48 hours doesn't help a patient sitting in front of you now. And the patient who walks out without an answer is the patient who might not come back.
- Revenue timing. One-visit care plans versus two-visit care plans change the revenue picture of a small clinic in a way the monthly lab statement never reveals.
The POC side had hidden costs too—I'm not pretending otherwise. Cartridges expire, and if staff run a test without updating to the new lot code, you burn inventory on errors. But here's the crucial difference: I could see, measure, and manage those POC costs. The lab's costs lived in small print and separate invoices that finance chased down to reconcile.
The counterintuitive conclusion: the lab's per-test price was about 30% lower, but its all-in cost per decision-ready result was not lower. Don't hold me to the exact payback math—I'd have to dig through old spreadsheets—but our POC analyzer paid for itself in roughly 14 months. That's the number I'd want if I were standing where you are.
Round 4: Operations—What the Price Sheet Doesn't Measure
I expected this round to be a tie. It wasn't.
With the central lab, a nurse had to complete the requisition, label the tubes, package and log the sample, coordinate with the courier, call the lab twice for status updates, and file results when they finally landed. I watched that process for a week. It is not a fast process, and it is not a cheap process—it just hides its cost in payroll instead of invoices.
With a POC analyzer, the same nurse runs the panel in the exam room while the patient is still there. Fifteen minutes later, the medical director has the numbers, and the patient leaves with a plan. Our clinic does a lot of wound care follow-ups and minor procedures—we buy more wound care products than I expected when I took this job—and that speed is the difference between a treatment plan set in one visit and a "we'll call you next week" that never gets resolved.
I'll also say the operational comparison is not "POC involves quality control, lab doesn't." It's "deal with quality control" versus "deal with shipping, rejected samples, and phone tag." I know which one my team preferred from week two.
So Which Should You Choose?
Here's the practical advice I wish I'd gotten instead of a lazy "it depends."
Choose point-of-care testing if you have steady volume on a small set of common tests; if your patients are often seen once and may not return; or if a same-visit clinical decision genuinely changes the outcome. It's also the stronger fit for multi-site operations where samples would otherwise travel long distances.
Choose the central lab if your volume is genuinely low, if most of your tests are esoteric panels that no POC cartridge covers, or if you have settings like overnight shifts where a machine would sit idle.
And whatever you're leaning toward, ask this before signing anything: "What's NOT included in this price?"
I've learned to ask "what's NOT included" before "what's the price." The vendor who lists all fees upfront—even if the total looks higher—usually costs less in the end.
The Bottom Line
This comparison is based on quotes I gathered in Q3 2024. Device pricing changes fast, so verify current rates before you budget. Ask your distributor whether the monthly minimum, operator training, and quality-control supplies are inside the number they quoted.
Also worth knowing: in the US, CLIA-waived status determines which POC tests a clinic can run without a full lab oversight structure. That's not a line item on any invoice, but it shapes which analyzers you're allowed to use. Check the FDA's current CLIA database before you commit.
I don't get to make the clinical call at our clinic—that's the medical director's job. But I do get to make the buying call, and the more transparent a vendor is about the full cost picture, the more likely I am to keep ordering from them. Whether I'm stocking wound care products, replacing a DPM6 monitor at a nursing station, or planning the next ultrasound expansion, the rule is the same: the price in front of you is rarely the price at the end of the commitment. Ask for the full list. If they can't give it to you in one sentence, that's your answer.